Amkor Technology Total Cost of Revenue decreased by 8.1% to $1.45B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 24.2%, from $1.16B to $1.45B. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 4.1% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.13B | $1.36B | $1.36B | $1.27B | $1.26B | $1.66B | $1.57B | $1.28B | $1.27B | $1.54B | $1.47B | $1.16B | $1.25B | $1.59B | $1.38B | $1.16B | $1.33B | $1.70B | $1.57B | $1.45B |
| QoQ Change | — | +19.6% | +0.5% | -6.7% | -1.2% | +32.4% | -5.4% | -18.8% | -0.5% | +21.1% | -4.3% | -21.0% | +7.3% | +27.2% | -13.0% | -15.8% | +14.2% | +28.1% | -7.6% | -8.1% |
| YoY Change | — | — | — | — | +10.8% | +22.6% | +15.4% | +0.4% | +1.2% | -7.4% | -6.3% | -8.9% | -1.7% | +3.3% | -6.1% | +0.0% | +6.4% | +7.1% | +13.8% | +24.2% |